Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Gene Therapy Development
Localising Lentiviral Transduction-Inserted CAR Cassettes in T Cells Using Xdrop
Gene Therapy Development
Professional Assay Services Offers GCLP-Compliant RNAscope, BASEscope, and miRNAscope
Gene Therapy Development
Revealing and Retrieving Highly Potent IFN-y Secretors Using an Xdrop Single-Cell Format Workflow
Stem Cell Therapy
Zebrafish Models May Hold the Answer to Cell Dedifferentiation
Traditionally, cell fate and differentiation were considered to be a one-way journey. However, recent research using animal models like zebrafish has challenged this perspective.
Oligo Chemistry
Transforming Oligonucleotide Manufacturing: A Transformative UK Collaboration
A new collaboration from the Medicines Manufacturing Innovation Centre is looking to change the face of oligonucleotide development.
Drug Discovery & Development
AstraZeneca and Daiichi Sankyo Share Results of IO Combination Therapy in Ib Clinical Trial
Preliminary results from phase Ib clinical trial, TROPION-Lung02, evaluating the antibody drug conjugate datopotamab deruxtecan in combination with pembrolizumab.